{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:19:18Z","timestamp":1788412758067,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2014.00163","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T08:40:21Z","timestamp":1403253621000},"source":"Crossref","is-referenced-by-count":8,"title":["Differential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines"],"prefix":"10.3389","volume":"4","author":[{"given":"Brittany Anne","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Rubatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Corcoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna K.","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Q.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William John","family":"Soper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Berchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharareh","family":"Siamakpour-Reihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouros","family":"Owzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeles Alvarez","family":"Secord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,6,20]]},"reference":[{"key":"B1","first-page":"807","article-title":"Angiogenesis: an update","volume":"9","author":"Diaz-Flores","year":"1994","journal-title":"Histol Histopathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2003.09.019","article-title":"Multiple regulatory pathways of vascular permeability factor\/vascular endothelial growth factor expression in tumors","volume":"17","author":"Mukhopadhyay","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"B3","first-page":"6161","article-title":"Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression","volume":"55","author":"Mukhopadhyay","year":"1995","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/sj.onc.1204271","article-title":"Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism","volume":"20","author":"Galy","year":"2001","journal-title":"Oncogene"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1158\/1078-0432.CCR-04-0056","article-title":"The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer","volume":"11","author":"Goodheart","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B6","first-page":"2485","article-title":"Distant metastases in ovarian cancer: association with p53 mutations","volume":"5","author":"Sood","year":"1999","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1677\/erc.1.00728","article-title":"Hypoxia-inducible factor-1 in human breast and prostate cancer","volume":"13","author":"Kimbro","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.4161\/cbt.5.5.2749","article-title":"Hypoxic microenvironment as a cradle for melanoma development and progression","volume":"5","author":"Michaylira","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1200\/JCO.2006.08.5415","article-title":"Targeted therapy for metastatic renal cell carcinoma","volume":"24","author":"Motzer","year":"2006","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S1359-6446(04)03202-7","article-title":"The HIF pathway as a therapeutic target","volume":"9","author":"Hewitson","year":"2004","journal-title":"Drug Discov Today"},{"issue":"1","key":"B11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","article-title":"DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination","volume":"127","author":"Korch","year":"2012","journal-title":"Gynecol Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1006\/gyno.2001.6464","article-title":"Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations","volume":"83","author":"Havrilesky","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"10","key":"B13","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-04-2398","article-title":"Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers","volume":"11","author":"Berchuck","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"7","key":"B14","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1158\/1078-0432.CCR-08-2430","article-title":"Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome","volume":"15","author":"Berchuck","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"3","key":"B15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy \u00e2\u20ac\u201c analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"},{"issue":"10","key":"B16","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"B17","doi-asserted-by":"crossref","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical Bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/path.1400","article-title":"Extracellular matrix remodeling: the role of matrix metalloproteinases","volume":"200","author":"Stamenkovic","year":"2003","journal-title":"J Pathol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","article-title":"Matrix metalloproteinases: they\u00e2\u20ac\u2122re not just for matrix anymore!","volume":"13","author":"McCawley","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S1074-5521(96)90178-7","article-title":"Matrix metalloproteinases and the development of cancer","volume":"3","author":"Coussens","year":"1996","journal-title":"Chem Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ijc.21421","article-title":"Vascular endothelial growth factor-regulated ovarian cancer invasion and migration involves expression and activation of matrix metalloproteinases","volume":"118","author":"Wang","year":"2006","journal-title":"Int J Cancer"},{"issue":"1","key":"B23","first-page":"89","article-title":"Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer","volume":"10","author":"Yabushita","year":"2003","journal-title":"Oncol Rep"},{"issue":"17","key":"B24","first-page":"5224","article-title":"Matrix metalloproteinases induce the release of vascular endothelial growth factor by ovarian carcinoma cells: implications for ascites formation","volume":"63","author":"Belotti","year":"2003","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0168-9525(90)90126-Q","article-title":"Metalloproteinases and their inhibitors in matrix remodeling","volume":"6","author":"Matrisian","year":"1990","journal-title":"Trends Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","article-title":"Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation","volume":"64","author":"Liotta","year":"1991","journal-title":"Cell"},{"issue":"4","key":"B27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.humimm.2012.11.021","article-title":"Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15","volume":"74","author":"Lin","year":"2013","journal-title":"Hum Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"34123","DOI":"10.1074\/jbc.M508155200","article-title":"Identification of MMP-15 as an apoptotic factor in cancer cells","volume":"280","author":"Abraham","year":"2005","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1155\/2007\/281727","article-title":"Matrix metalloproteinase expression patterns in luminal A type breast carcinomas","volume":"23","author":"Decock","year":"2007","journal-title":"Dis Markers"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/sj.bjc.6602630","article-title":"Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues","volume":"92","author":"Riddick","year":"2005","journal-title":"Br J Cancer"},{"issue":"3","key":"B31","first-page":"434","article-title":"Global expression analysis in uterine cervical cancer: metabolic pathways and altered genes","volume":"57","author":"V\u00c3\u00a1zquez-Ort\u00c3\u00adz","year":"2005","journal-title":"Rev Invest Clin"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T15:32:26Z","timestamp":1565537546000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2014.00163\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,20]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3389\/fonc.2014.00163","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,20]]}}}